INDIANAPOLIS — The “Sound Medicine” program for May 18 includes segments about inhalable insulin, a Type 2 diabetes treatment plan, and the dangers of laparoscopic power morcellation.
Will inhaled insulin succeed this time around? Of the 26 million people with diabetes, millions might benefit from a new alternative to insulin shots. The FDA is reviewing Afrezza, an inhalable insulin. Paris Roach, M.D., an associate professor of clinical medicine at the IU School of Medicine, discusses why MannKind decided to develop Afrezza after Pfizer pulled its inhalable insulin from the market in 2007 and what this could mean for diabetics.
Can effects of Type 2 diabetes be reversed? Osama Hamdy, M.D., an assistant professor at Harvard Medical School, joins “Sound Medicine” to talk about his new book, “The Diabetes Breakthrough.” The book outlines a 12-step fitness and workout plan that encourages people with Type 2 diabetes to lose at least 7 percent of their body fat. Dr. Hamdy discusses the significance of a 7 percent body fat loss, the Why WAIT fitness plan, and how his clinically proven program can prevent and reverse the effects of Type 2 diabetes.
Can laparoscopic power morcellation increase patients’ risk of cancer? In April, the FDA released a statement discouraging surgeons from using laparoscopic power morcellation for hysterectomies and the removal of uterine fibroids. According to the FDA, using power morcellation for these procedures carries the risk of spreading cancer around a woman’s abdomen and pelvis. Jessica Shepherd, M.D., MBA, director of minimally invasive gynecology at the University of Illinois College of Medicine at Chicago, discusses the FDA’s warning, the risk of spreading cancer, and surgical alternatives to laparoscopic power morcellation.
Meeting the needs of dying patients:Larry Cripe, M.D., an associate professor of medicine at the IU School of Medicine, reflects upon the death of a patient whose dying words inspired him to pay deliberate attention to how he can help meet the needs of dying patients.
“Sound Medicine” covers controversial ethics topics, breakthrough research studies and the day-to-day application of recent advancements in medicine. It’s also available via podcast and Stitcher Radio for mobile phones and iPads and posts updates on Facebook and Twitter.
Co-produced by the IU School of Medicine and WFYI Public Radio (90.1 FM) and underwritten in part by Indiana University-Purdue University Indianapolis, “Sound Medicine” airs on the following Indiana public radio stations: WBSB (Anderson, 89.5 FM), WFIU (Bloomington, 103.7 FM; Columbus, 100.7 FM; Kokomo, 106.1 FM; Terre Haute, 95.1 FM), WNDY (Crawfordsville, 91.3 FM), WVPE (Elkhart/South Bend, 88.1 FM), WNIN (Evansville, 88.3 FM), WBOI (Fort Wayne, 89.1 FM), WFCI (Franklin, 89.5 FM), WBSH (Hagerstown/New Castle, 91.1 FM), WFYI (Indianapolis), WBSW (Marion, 90.9 FM), WBST (Muncie, 92.1 FM), WBSJ (Portland, 91.7 FM), WLPR (Lake County, 89.1 FM) and WBAA (West Lafayette, 101.3 FM).
“Sound Medicine” is also broadcast on these public radio stations across the country: KSKA (Anchorage, Alaska), KTNA (Talkeetna, Alaska), KUHB (Pribilof Islands, Alaska), KUAF (Fayetteville and Fort Smith, Ark.), KIDE (Hoopa Valley, Calif.), KRCC (Colorado Springs, Colo.), KEDM (Monroe, La.), WCMU (Mount Pleasant, Mich.), WCNY and WRVO-1 (Syracuse, N.Y.), KMHA (Four Bears, N.D.), WYSU (Youngstown, Ohio), KPOV (Bend, Ore.), KEOS (College Station, Texas), HPPR (High Plains Public Radio), which includes: KCSE (Lamar, Col.), KZNK (Brewster, Kan.), KZCK (Colby, Kan.), KZNZ (Elkhart, Kan.), KZAN (Hays, Kan.), KZNA (Hill City, Kan.), KGUY (Guymon, Okla.), KJJP (Amarillo, Texas), KTXP (Bushland, Texas), KTDH (Dalhart, Texas), KTOT (Spearman-Perryton, Texas).
Please check local listings for broadcast dates and times.